Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	22869
Country	United States

Received	2015-09-29 08:51
Peer-Review Started	2015-10-02 14:58
To Make the First Decision	2015-10-27 11:30
Return for Revision	2015-11-04 15:35
Revised	2016-01-13 07:56
Second Decision	2016-02-25 16:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-03-14 12:02
Articles in Press	2016-03-14 12:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-05-05 15:58
Publish the Manuscript Online	2016-05-17 12:43

ISSN	1948-9366 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Minireviews
Article Title	Inflammatory bowel disease surgery in the biologic era
Manuscript Source	Invited Manuscript
All Author List	Linda Ferrari, Mukta K Krane and Alessandro Fichera
Funding Agency and Grant Number
Corresponding Author	Alessandro Fichera, MD, FACS, FASCRS, University of Washington Medical Center, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195-6410, United States. afichera@uw.edu
Key Words	Inflammatory bowel disease; Anti-tumour necrosis factor alpha agents; Ulcerative colitis; Crohn’s disease; Infliximab
Core Tip	We review the relationship between biologic agents and surgery in the treatment of inflammatory bowel disease. We also discuss in detail perioperative risks and complications in this setting.
Publish Date	2016-05-17 12:43
Citation	Ferrari L, Krane MK, Fichera A. Inflammatory bowel disease surgery in the biologic era. World J Gastrointest Surg 2016; 8(5): 363-370
URL	http://www.wjgnet.com/1948-9366/full/v8/i5/363.htm
DOI	http://dx.doi.org/10.4240/wjgs.v8.i5.363

Full Article (PDF)	WJGS-8-363.pdf
Full Article (Word)	WJGS-8-363.doc
Manuscript File	22869-Review.docx
Answering Reviewers	22869-Answering reviewers.pdf
Audio Core Tip	22869-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22869-Conflict-of-interest statement.pdf
Copyright License Agreement	22869-Copyright assignment.pdf
Peer-review Report	22869-Peer-review(s).pdf
Scientific Misconduct Check	22869-Scientific misconduct check.pdf
Scientific Editor Work List	22869-Scientific editor work list.pdf